Marah Elizabeth Gotcsik, MD | |
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
(907) 729-1044 | |
Not Available |
Full Name | Marah Elizabeth Gotcsik |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 4315 Diplomacy Dr, Anchorage, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275723108 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 7095 (Alaska) | Primary |
Entity Name | Alaska Native Tribal Health Consortium |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones of the first tissues undergoing metastasis are the lymph nodes surrounding the tumour.
Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.
› Verified 1 days ago
Entity Name | Yukon-kuskokwim Health Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515 |
News Archive
Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones of the first tissues undergoing metastasis are the lymph nodes surrounding the tumour.
Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.
› Verified 1 days ago
Entity Name | Maniilaq Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861698805 PECOS PAC ID: 6103881792 Enrollment ID: O20041123000372 |
News Archive
Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones of the first tissues undergoing metastasis are the lymph nodes surrounding the tumour.
Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.
› Verified 1 days ago
Entity Name | Southcentral Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones of the first tissues undergoing metastasis are the lymph nodes surrounding the tumour.
Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Marah Elizabeth Gotcsik, MD 4201 Tudor Centre Dr, Suite 320, Anchorage, AK 99508-5904 Ph: (907) 729-8624 | Marah Elizabeth Gotcsik, MD 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-1044 |
News Archive
Life Science Intelligence (LSI) announced today that more than 30 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on May 12, 2010 at 11 a.m. Eastern, sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones of the first tissues undergoing metastasis are the lymph nodes surrounding the tumour.
Illumina, Inc. has announced that the United States Patent and Trademark office has ordered the re-examination of U.S. Patent Nos. 6,355,432 and 6,646,243.
› Verified 1 days ago
Elizabeth Mumford Galloway, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2211 Fax: 509-479-0214 | |
Wendy Bailey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite A-351, Anchorage, AK 99508 Phone: 907-212-4824 Fax: 907-212-4831 | |
Jay D. Johnson, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3801 Lake Otis Pkwy Ste 200, Anchorage, AK 99508 Phone: 907-212-6900 | |
Dr. Stephen Scott Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2841 Debarr Rd, Bldg A, Suite 23, Anchorage, AK 99508 Phone: 907-677-1864 Fax: 907-868-5167 | |
Dr. Rachel Mauryce Kerford Lescher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508 Phone: 907-729-1000 Fax: 907-729-5244 | |
Dr. James Monroe Nesbitt Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3200 Providence Dr, Administration Office, Anchorage, AK 99508 Phone: 907-261-5098 Fax: 907-743-2358 | |
Dr. Emily Margaret Reilly, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-4068 |